1 |
Anderson, B.F., H. Baker, M. Norris, G.E. Rice, and D.W. Bake. 1989. Structure of human lactoferrin; Crystallographic structure analysis and refinement at 2.8Å resolution. J. Mol. Biol. 209, 711-734
|
2 |
Cregg, J.M., J.L. Cereghino, J. Shi, and D.R. Higgings. 2000. Recombinant protein expression in Pichia pastoris. Mol. Biotechnol. 16, 23-52
|
3 |
Schmitt, M.E., A.B. Timothy, and B.L. Trumpower. 1990. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic. Acids Res. 18, 3091-3092
|
4 |
Schorer, C.A., J.J. Clare, W.R. McCombie, M.A. Romanos, and K. Sreekrishna. 1994. Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology 12, 181-184
|
5 |
Tschopp, J.F., G. Dverlow, R. Kosson, W. Craig, and L. Grinna. 1987. High-level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris. Biotechnology 5, 1305-1308
|
6 |
Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual 1st ed. Cold Spring Harbor Laboratory, New York
|
7 |
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
|
8 |
Moriuchi, M. and H. Moriuchi. 2001. A milk protein lactoferrin enhances Human T Cell Leukemia Virus Type 1 and suppresses HIV-1 infection. J. Immunol. 166, 4231-4236
|
9 |
Romanos, M.A., C.A. Scorer, and J.J. Clare. 1992. Foreign gene expression in yeast: review. Yeast 8, 423-488
|
10 |
Arnold, R.R., J.E. Russell, W.J. Champion, M. Brewer, and J.J. Gauthier. 1982. Bactericidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation. Infect. Immun. 35, 792-799
|
11 |
Aisen, P. and I. Listowsky. 1980. Iron transport and storage proteins. Annu. Rev. Biochem. 49, 357-393
|
12 |
Doring, G., T. Pfestrof, K. Botzenhart, and M.A. Abdallah. 1988. Iron-chelating substances and inflammation. Scand. J. Gastroenterol. 23, 68-69
|
13 |
Ellison III, R.T. and T.J. Giehl. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88, 1080 - 1091
|
14 |
Arnold, R.R., M. Brewer, and J.J. Gauthier. 1980. Bactericidal activity of human lactoferrin : sensitivity of a variety of microorganisms. Infect. Immun. 28, 893-898
|
15 |
Ikeda, M., A. Nozaki, K. Sugiyama, T. Tanaka, A. Naganuma, K. Tanaka, H. Sekihara, K. Shimotohno, M. Saito, and N. Kato. 2000. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultures cells. Vir. Res. 66, 51-63
|
16 |
Ainscough, E.W., A.M. Brodie, and J.E. Plowman. 1979. The chromium, manganese, cobalt and copper complexes of human lactoferrin. Inorg. Chim. Acta. 33, 149-153
|
17 |
Akin, D.T., M.Q. Lu, S. Kendall, J. Rundegren, and R.R. Arnold. 1994. Bactericidal activity of different forms of lactoferrin. Adv. Exp. Med. Biol. 357, 61-70
|
18 |
Sreekrishna, K., J.F. Tschopp, and M. Fuke. 1987. Invertase gene (SUC2) of Saccharomyces cerevisiae as a dominant marker for transformation Pichia pastoris. Gene 59, 115-125
|
19 |
Ellison III, R.T., T.J. Giehl, and F.M. LaForce. 1988. Damage of the outer membrane of the enteric Gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56, 2774-2781
|